Two-Domain Vascular Disruptive Agents in Cancer Therapy
Journal:
Current Cancer Drug Targets
Volume:
4
Page:
501-509
Author(s):
Stanislaw Szala
The Relationship Between Oncogene Expression and Clinical Outcome in Endometrial Carcinoma
Journal:
Current Cancer Drug Targets
Volume:
4
Page:
511-520
Author(s):
Noriyuki Takai, Tami Ueda, Masakazu Nishida, Kaei Nasu and Isao Miyakawa
Nuclear Architecture and Gene Expression in the Quest for Novel Therapeutics
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
2851-2860
Author(s):
Frank O. Fackelmayer
Pituitary Adenylate Cyclase Activating Polypeptide: A Potential Neuroprotective Peptide
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
2861-2889
Author(s):
Aniko Somogyvari-Vigh and Dora Reglodi
Combining Gene Therapy and Radiation Against Cancer
Journal:
Current Gene Therapy
Volume:
4
Page:
231-248
Author(s):
Daila S. Gridley and James M. Slater
Undermining Tumor Angiogenesis by Gene Therapy: An Emerging Field
Journal:
Current Gene Therapy
Volume:
4
Page:
297-308
Author(s):
S. Indraccolo
Electroporation Gene Therapy: New Developments In Vivo and In Vitro
Journal:
Current Gene Therapy
Volume:
4
Page:
309-316
Author(s):
Shulin Li
Pharmacogenomics of Cytochrome P450 Enzymes in Tumours
Journal:
Current Pharmacogenomics
Volume:
2
Page:
243-254
Author(s):
Diane Downie, Patrick H. Rooney, Morag C.E. McFadyen and Graeme I. Murray
Human Reduced Folate Carrier Gene and Transcript Variants: Functional, Physiologic, and Pharmacologic Consequences
Journal:
Current Pharmacogenomics
Volume:
2
Page:
287-298
Author(s):
Larry H. Matherly
Growth Factor Signaling and Resistance to Cancer Chemotherapy
Journal:
Current Topics in Medicinal Chemistry
Volume:
4
Page:
1345-1354
Author(s):
Zunyan Dai, Ying Huang and Wolfgang Sadee